Abeona Therapeutics (ABEO) Current Leases (2019 - 2026)

Abeona Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Current Leases rose 107.5% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 107.5% YoY), while the FY2025 annual figure was $864000.0, up 4.98% from the prior year.
• Current Leases for Q1 2026 stood at $1.3 million, up from $864000.0 in the prior quarter.
• The five-year high for Current Leases was $1.8 million in Q1 2022, with the low at $102000.0 in Q3 2025.
• The 5-year median for Current Leases is $1.3 million (2026), against an average of $1.3 million.
• The sharpest annual moves came in 2025 and 2026: Current Leases sank 90.35% in 2025, then jumped 107.5% in 2026.
• Abeona Therapeutics' Current Leases stood at $1.8 million in 2022, then slumped by 43.71% to $998000.0 in 2023, then retreated by 17.54% to $823000.0 in 2024, then climbed by 4.98% to $864000.0 in 2025, then surged by 47.22% to $1.3 million in 2026.
• Business Quant data shows ABEO's Current Leases at $1.3 million in Q1 2026, $864000.0 in Q4 2025, and $102000.0 in Q3 2025.